Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Announces Upcoming Participation at January Conferences 2021-12-31 21:00
GBB Closed the A Round Financing with Newly Joined FutureX Capital 2021-12-31 20:44
Zepp Health Provides Updates to Guidance and Share Repurchases 2021-12-31 20:00
Landmark international innovation and entrepreneurship competition concludes in China's Chongqing with top prize worth 100 mln yuan 2021-12-31 19:15
GenFleet Therapeutics Raises $75 Million in Series C Financing Led by Huagai Capital, to Advance Innovative Pipeline Highlighting Cutting-edge Therapies 2021-12-31 19:00
China Medical System (867.HK)'s Latest MSCI ESG Rating Unchanged at AA, Leading the Industry Globally 2021-12-30 20:00
Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology 2021-12-30 19:18
Dada Group and Kimberly-Clark China Strengthen Partnership to Create New Growth of Healthcare Brands in On-demand Retail 2021-12-30 10:57
iMEDISYNC UNVEILS WORLD'S FIRST INTEGRATED WIRELESS BRAIN EEG at CES 2022 2021-12-30 00:00
China Jo-Jo Drugstores Receives 2021 China ESG Golden Awards- Sustainability Award from Sina Finance 2021-12-29 21:30
SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical 2021-12-29 20:30
EOFlow and Zihipp Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & NASH 2021-12-28 22:00
Akeso's IL-17A MONOCLONAL ANTIBODY (GUMOKIMAB) COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS 2021-12-28 12:30
Regor Therapeutics Announces U.S. FDA Authorization to Conduct Regor's First-in-Human Clinical Trial with the Next Generation Targeted Inhibitor RGT-419B for Oncology 2021-12-28 09:00
I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors 2021-12-27 21:00
Kintor Pharma Provides Update on One of its Three Multi-Regional Phase 3 Trials of Proxalutamide for COVID-19 2021-12-27 20:19
Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase 2021-12-24 16:30
Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility' 2021-12-23 20:00
Akeso's PCSK9 MONOCLONAL ANTIBODY (EBRONUCIMAB) EARLY COMPLETION OF PATIENT ENROLLMENT IN A PHASE III CLINICAL TRIAL FOR PRIMARY HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA 2021-12-23 12:42
Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China 2021-12-23 11:59
1 181 182 183 184 185 801